We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

Federal court denies HHS motion to seal documents in medical-device whistleblower
  • Shook Hardy & Bacon LLP
  • USA
  • January 10 2013

A federal court in the District of Columbia has denied the government's request to seal an exhibit in Freedom of Information Act litigation over records


Veracyte increases IPO target to $81 million
  • Shook Hardy & Bacon LLP
  • USA
  • October 31 2013

South San Francisco-based Veracyte, Inc., which earlier this year completed a $28-million Series C financing round to expand and roll out its thyroid


Bipartisan bill would curb FDA’s medical apps oversight
  • Shook Hardy & Bacon LLP
  • USA
  • October 31 2013

A bipartisan group of U.S representatives has introduced the Sensible Oversight for Technology which Advances Regulatory Efficiency (SOFTWARE) Act (H


Diagnostics companies join to provide infectious-disease testing in developing countries
  • Shook Hardy & Bacon LLP
  • USA
  • August 1 2013

According to a news source, Co-Diagnostics has entered a joint venture with DNA Logix to bring genetic-testing products and services to highburden


Ultragenyx files with SEC to raise $86.25 million in IPO
  • Shook Hardy & Bacon LLP
  • USA
  • November 21 2013

Orphan disease drug developer Ultragenyx Pharmaceutical Inc. has filed a registration statement with the U.S. Securities and Exchange Commission


Federal Circuit refuses to rehear ruling on the finality of patent infringement determinations
  • Shook Hardy & Bacon LLP
  • USA
  • November 21 2013

The Federal Circuit Court of Appeals has denied a petition for panel rehearing and rehearing en banc in 10-year-old litigation that concluded with


Newsbytes
  • Shook Hardy & Bacon LLP
  • USA
  • November 21 2013

The U.S. Patent and Trademark Office extends the 60-day comment period relating to the paperwork burdens for Initial Patent Applications. Written


Biotech set to raise $86 million in IPO to support cancer and IEM products
  • Shook Hardy & Bacon LLP
  • USA
  • June 20 2013

Agios Pharmaceuticals, Inc. has filed a registration statement with the U.S. Securities and Exchange Commission indicating its intent to raise up to


President’s budget proposes banning “pay for delay” agreements
  • Shook Hardy & Bacon LLP
  • USA
  • April 18 2013

The pharmaceutical industry has weighed in on President Barack Obama's proposed 2014 fiscal year budget, finding much to criticize, including a


Tetragenetics Inc. receives $826 million grant for malaria vaccine
  • Shook Hardy & Bacon LLP
  • USA
  • April 18 2013

Tetragenetics Inc. has received an $826-million Phase 2 grant as well as new partnerships with two drug companies, according to a news source. The